TRACK BRANDS ON AI
Monitor your brand, company, or product's online reputation in AI responses
Searching...
Loading...
It's taking longer than usual, we might be experiencing higher load.
Give it a few more seconds or try again in a moment.
Give it a few more seconds or try again in a moment.
Searching...
Loading...
What does AI know about Mannkind Corporation ?
What does OpenAI free version (gpt-3.5-turbo) know about Mannkind Corporation?
| Last request | 21.12.2023
(There is a high chance that below response is an AI hallucination) |
| Well Known | No |
| Description | Mannkind Corporation is a biopharmaceutical company that develops and commercializes therapeutic products for diabetes and other diseases. |
| Most Notable Achievements | Mannkind Corporation has developed a revolutionary inhalable insulin product, Afrezza, which has been approved by the FDA. |
| The Most Negative Fact | Mannkind Corporation has struggled to gain market share for Afrezza, and the product has not been as successful as initially hoped. |
| Competition | None |
| Share with friends |
Register your email below to unlock features!
Don't like the AI answers? Who can help me Change them?
What does OpenAI paid version (gpt-4) know about Mannkind Corporation?
| Request date | |
| Well Known | No |
| Description | Mannkind Corporation is a biopharmaceutical company that focuses on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. |
| Most Notable Achievements | Mannkind Corporation's Afrezza, an inhaled insulin product, has been approved by the FDA for the treatment of diabetes. |
| The Most Negative Fact | Mannkind Corporation has faced financial struggles and has had difficulty gaining widespread adoption of its products. |
| Competition | None |
| Share with friends |
What does Google AI (PaLM) know about Mannkind Corporation?
| Last request | 21.12.2023 |
| Well Known | yes |
| Description | MannKind Corporation is an American pharmaceutical company that develops and commercializes inhaled insulin products for the treatment of diabetes. |
| Most Notable Achievements | MannKind Corporation has developed a new inhaled insulin product called Afrezza, which is the first inhaled insulin product approved by the U.S. Food and Drug Administration (FDA). |
| The Most Negative Fact | MannKind Corporation has been criticized for its high price for Afrezza, which is more expensive than other insulin products. |
| Competition | None |
What does Microsoft Bing AI know about Mannkind Corporation?
| Well Known | No |
| Description | eesc ronearompsue tstdiconned vtCdehatad atp eMhadpkaacin i rssa lrcimbstsoa rc tpo eili e oteaorater uaisaueiocynlpfa mdnbcmrhzi.nopihdo |
| Most Notable Achievements | ac eutaw oeblr,adhn cM lz iAnarnl Crotenr osndzpiapydeyaeto er dpaphbn fanaabv siops ennlvku oehihAlder,e tFhiDriioohu . v |
| The Most Negative Fact | sdzosk hutheotep iroc rla lptalfAgMinesyoCmaaannsh tsa rro onaikhe suunecsitnpnrahseb f l dggrdao oa. n, tfattsirue z ra id ed enc |
| Competition | oenN |
Register your email below to unlock features!
Looks like you haven't registered an account yet?
Just search for a brand, person or top-list BELOW and register your email on the search results page:
